asco.org4d
Resilience Skills Training Program
The Resilience Skills Training Program aims to improve physician wellness in oncology through a proactive approach. The program targets current trainees to help create a culture change surrounding ...
asco.org4d
Staff Well-Being & Development
Recruiting and developing oncology practice staff takes care and strategy. ASCO can be a unique resource as you search for ideal candidates and work to bolster the expertise and efficiency of your ...
asco.org5d
Tumor suppressor genes (TSG), treatment, and survival in de novo metastatic hormone-sensitive prostate cancer.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org5d
Comparison of immunohistochemistry (IHC) and quantitative RT-PCR: ER, PR, and HER2 receptor status.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org5d
Management of growing teratoma syndrome: Aachen University experience.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org5d
Surgical management of testicular cancer patients with complex postchemotherapy residual masses: Aachen University experience.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org5d
Long-term outcomes of radiotherapy for stage II testicular seminoma: The Mayo Clinic experience.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org5d
Management of residual nonretroperitoneal disease in nonseminomatous germ-cell tumors (NSGCT).
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org5d
Efficacy and hematologic toxicity of carboplatin and talazoparib combination therapy in BRCA mutated patients.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org5d
A phase I study of carboplatin and talazoparib in patients with and without DNA repair mutations.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org5d
Comprehensive molecular profiling of advanced gastric cancer (AGC) using NGS and immunohistochemistry (IHC).
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org5d
Impact of Medicaid expansion on diagnosis and management of patients with testicular cancer.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...